PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
60.43%
Revenue growth above 1.5x 6247.T's 22.60%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
95.88%
Gross profit growth above 1.5x 6247.T's 32.60%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
1795.68%
EBIT growth above 1.5x 6247.T's 202.22%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
1274.00%
Operating income growth above 1.5x 6247.T's 370.49%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
742.67%
Net income growth above 1.5x 6247.T's 189.96%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
760.00%
EPS growth above 1.5x 6247.T's 190.12%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
760.00%
Diluted EPS growth above 1.5x 6247.T's 190.12%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-90.82%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-16.54%
Negative 5Y CAGR while 6247.T stands at 40.89%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-32.65%
Negative 3Y CAGR while 6247.T stands at 23.76%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
No Data
No Data available this quarter, please select a different quarter.
104.34%
Positive 10Y CAGR while 6247.T is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-46.33%
Negative 5Y net income/share CAGR while 6247.T is 216.76%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-45.58%
Negative 3Y CAGR while 6247.T is 133.17%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-67.62%
Negative equity/share CAGR over 10 years while 6247.T stands at 38.71%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
143.76%
5Y equity/share CAGR above 1.5x 6247.T's 37.40%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
119.32%
3Y equity/share CAGR above 1.5x 6247.T's 30.72%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.10%
AR growth of 0.10% while 6247.T is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-37.71%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-15.37%
Negative asset growth while 6247.T invests at 7.07%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
9.43%
1.25-1.5x 6247.T's 7.55%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-37.98%
We’re deleveraging while 6247.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
7.31%
We expand SG&A while 6247.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.